Advertisement
Research Article

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas

  • Sveinung W. Sorbye mail,

    sveinung.sorbye@unn.no

    Affiliations: Department of Clinical Pathology, University Hospital of North Norway, Tromso, Norway, Institute of Medical Biology, University of Tromso, Tromso, Norway

    X
  • Thomas K. Kilvaer,

    Affiliations: Institute of Medical Biology, University of Tromso, Tromso, Norway, Institute of Clinical Medicine, University of Tromso, Tromso, Norway

    X
  • Andrej Valkov,

    Affiliations: Department of Clinical Pathology, University Hospital of North Norway, Tromso, Norway, Institute of Medical Biology, University of Tromso, Tromso, Norway

    X
  • Tom Donnem,

    Affiliations: Department of Oncology, University Hospital of North Norway, Tromso, Norway, Institute of Clinical Medicine, University of Tromso, Tromso, Norway

    X
  • Eivind Smeland,

    Affiliation: Department of Oncology, University Hospital of North Norway, Tromso, Norway

    X
  • Khalid Al-Shibli,

    Affiliations: Institute of Medical Biology, University of Tromso, Tromso, Norway, Department of Pathology, Nordland Central Hospital, Bodo, Norway

    X
  • Roy M. Bremnes,

    Affiliations: Department of Oncology, University Hospital of North Norway, Tromso, Norway, Institute of Clinical Medicine, University of Tromso, Tromso, Norway

    X
  • Lill-Tove Busund

    Affiliations: Department of Clinical Pathology, University Hospital of North Norway, Tromso, Norway, Institute of Medical Biology, University of Tromso, Tromso, Norway

    X
  • Published: October 05, 2012
  • DOI: 10.1371/journal.pone.0047068

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.